Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
Chimeric antigen receptor (CAR)-T cell therapyYukimi Sakoda, Koji Tamada
International Journal of Hematology|October 30, 2022
Novel technologies for improving the safety and efficacy of CAR-T cell therapyKeisuke Ohta, Yukimi Sakoda, Koji Tamada
Cancer Immunology, Immunotherapy : CII|February 7, 2026
CAR-T cells co-expressing IL-7 and CCL19 promote epitope spreading to enhance antitumor immunityKeishi Adachi, Yukimi Sakoda, Tsuneyasu Kaisho, et al.
Cancer Science|August 22, 2019
Improved survival of chimeric antigen receptor-engineered T (CAR-T) and tumor-specific T cells caused by anti-programmed cell death protein 1 single-chain variable fragment-producing CAR-T cellsMasao Nakajima, Yukimi Sakoda, Keishi Adachi, et al.
Cancer Medicine|April 9, 2023
Therapeutic effects of anti-GM2 CAR-T cells expressing IL-7 and CCL19 for GM2-positive solid cancer in xenograft modelTakahiro Sasaki, Yukimi Sakoda, Keishi Adachi, et al.
Molecular Cancer Therapeutics|June 15, 2026
Short-term manufacturing of IL-7/CCL19-expressing CAR-T cells enhances and prolongs therapeutic effects in solid tumor modelsKohei Sakai, Yukimi Sakoda, Keishi Adachi, et al.
Molecular Cancer Therapeutics|October 22, 2021
Enhanced Antitumor Responses of Tumor Antigen-Specific TCR T Cells Genetically Engineered to Produce IL7 and CCL19Yoshihiro Tokunaga, Takahiro Sasaki, Shunsuke Goto, et al.
Nature Biotechnology|March 6, 2018
IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumorKeishi Adachi, Yosuke Kano, Tomohiko Nagai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Redirecting gene-modified T cells toward various cancer types using tagged antibodiesKoji Tamada, Degui Geng, Yukimi Sakoda, et al.
Cancer Immunology, Immunotherapy : CII|February 9, 2021
Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor modelsShunsuke Goto, Yukimi Sakoda, Keishi Adachi, et al.
Pageof 12